nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinastine—ABCB1—Vismodegib—skin cancer	0.159	0.182	CbGbCtD
Epinastine—CYP3A4—Temozolomide—skin cancer	0.137	0.157	CbGbCtD
Epinastine—CYP3A4—Imiquimod—skin cancer	0.137	0.157	CbGbCtD
Epinastine—CYP2D6—Vemurafenib—skin cancer	0.118	0.135	CbGbCtD
Epinastine—CYP3A4—Vismodegib—skin cancer	0.0953	0.109	CbGbCtD
Epinastine—ABCB1—Dactinomycin—skin cancer	0.0836	0.0954	CbGbCtD
Epinastine—CYP3A4—Vemurafenib—skin cancer	0.0753	0.086	CbGbCtD
Epinastine—ABCB1—Docetaxel—skin cancer	0.0431	0.0493	CbGbCtD
Epinastine—CYP3A4—Docetaxel—skin cancer	0.0258	0.0295	CbGbCtD
Epinastine—HRH1—nose—skin cancer	0.013	0.131	CbGeAlD
Epinastine—HTR2A—hindlimb—skin cancer	0.00513	0.0517	CbGeAlD
Epinastine—HTR7—nerve—skin cancer	0.00501	0.0505	CbGeAlD
Epinastine—HTR2A—appendage—skin cancer	0.0044	0.0444	CbGeAlD
Epinastine—HTR7—endothelium—skin cancer	0.00426	0.043	CbGeAlD
Epinastine—HTR7—blood vessel—skin cancer	0.00393	0.0396	CbGeAlD
Epinastine—HRH2—skin of body—skin cancer	0.00358	0.0361	CbGeAlD
Epinastine—HTR2A—nerve—skin cancer	0.00312	0.0315	CbGeAlD
Epinastine—HTR7—neck—skin cancer	0.00281	0.0283	CbGeAlD
Epinastine—HTR2A—endothelium—skin cancer	0.00266	0.0268	CbGeAlD
Epinastine—HTR2A—blood vessel—skin cancer	0.00245	0.0247	CbGeAlD
Epinastine—HRH2—head—skin cancer	0.00234	0.0235	CbGeAlD
Epinastine—HRH1—nipple—skin cancer	0.00212	0.0214	CbGeAlD
Epinastine—ADRA2A—nipple—skin cancer	0.00208	0.021	CbGeAlD
Epinastine—HTR7—connective tissue—skin cancer	0.00202	0.0203	CbGeAlD
Epinastine—HTR7—epithelium—skin cancer	0.00191	0.0193	CbGeAlD
Epinastine—ADRA1A—epithelium—skin cancer	0.00185	0.0186	CbGeAlD
Epinastine—HTR2A—neck—skin cancer	0.00175	0.0177	CbGeAlD
Epinastine—HRH2—lymph node—skin cancer	0.00164	0.0165	CbGeAlD
Epinastine—ABCB1—blood vessel—skin cancer	0.00161	0.0162	CbGeAlD
Epinastine—HRH1—connective tissue—skin cancer	0.00151	0.0152	CbGeAlD
Epinastine—ADRA2A—connective tissue—skin cancer	0.00148	0.0149	CbGeAlD
Epinastine—HRH1—epithelium—skin cancer	0.00143	0.0144	CbGeAlD
Epinastine—ADRA1A—lymphoid tissue—skin cancer	0.00142	0.0143	CbGeAlD
Epinastine—HTR7—female reproductive system—skin cancer	0.00142	0.0143	CbGeAlD
Epinastine—CYP2B6—skin of body—skin cancer	0.00139	0.014	CbGeAlD
Epinastine—HTR2A—connective tissue—skin cancer	0.00126	0.0127	CbGeAlD
Epinastine—HRH1—mammalian vulva—skin cancer	0.00124	0.0125	CbGeAlD
Epinastine—ADRA2A—mammalian vulva—skin cancer	0.00122	0.0123	CbGeAlD
Epinastine—Eye irritation—Fluorouracil—skin cancer	0.00121	0.0481	CcSEcCtD
Epinastine—HTR2A—epithelium—skin cancer	0.00119	0.012	CbGeAlD
Epinastine—HTR7—head—skin cancer	0.00119	0.012	CbGeAlD
Epinastine—ADRA1A—head—skin cancer	0.00115	0.0115	CbGeAlD
Epinastine—CYP2B6—lymphoid tissue—skin cancer	0.00113	0.0114	CbGeAlD
Epinastine—Lacrimation increased—Fluorouracil—skin cancer	0.00112	0.0446	CcSEcCtD
Epinastine—Upper respiratory tract infection—Imiquimod—skin cancer	0.00109	0.0434	CcSEcCtD
Epinastine—CYP2B6—female reproductive system—skin cancer	0.00109	0.011	CbGeAlD
Epinastine—HRH1—female reproductive system—skin cancer	0.00106	0.0107	CbGeAlD
Epinastine—ADRA2A—female reproductive system—skin cancer	0.00104	0.0105	CbGeAlD
Epinastine—Sinusitis—Imiquimod—skin cancer	0.000984	0.039	CcSEcCtD
Epinastine—Rhinitis—Imiquimod—skin cancer	0.000944	0.0374	CcSEcCtD
Epinastine—Pharyngitis—Imiquimod—skin cancer	0.000935	0.0371	CcSEcCtD
Epinastine—CYP2B6—head—skin cancer	0.000908	0.00915	CbGeAlD
Epinastine—Pruritus—Vismodegib—skin cancer	0.000898	0.0356	CcSEcCtD
Epinastine—HRH1—head—skin cancer	0.000887	0.00894	CbGeAlD
Epinastine—HTR2A—female reproductive system—skin cancer	0.000887	0.00894	CbGeAlD
Epinastine—Eye irritation—Docetaxel—skin cancer	0.000875	0.0347	CcSEcCtD
Epinastine—ADRA2A—head—skin cancer	0.000871	0.00878	CbGeAlD
Epinastine—Cough—Vemurafenib—skin cancer	0.000839	0.0333	CcSEcCtD
Epinastine—CYP3A4—female reproductive system—skin cancer	0.000821	0.00827	CbGeAlD
Epinastine—Lacrimation increased—Docetaxel—skin cancer	0.000811	0.0322	CcSEcCtD
Epinastine—CYP2D6—female reproductive system—skin cancer	0.000808	0.00814	CbGeAlD
Epinastine—ABCB1—epithelium—skin cancer	0.000782	0.00788	CbGeAlD
Epinastine—Infection—Vemurafenib—skin cancer	0.000779	0.0309	CcSEcCtD
Epinastine—HTR2A—head—skin cancer	0.000741	0.00747	CbGeAlD
Epinastine—Cough—Imiquimod—skin cancer	0.000715	0.0284	CcSEcCtD
Epinastine—ABCB1—mammalian vulva—skin cancer	0.000678	0.00684	CbGeAlD
Epinastine—CYP2D6—head—skin cancer	0.000675	0.0068	CbGeAlD
Epinastine—Nasopharyngitis—Fluorouracil—skin cancer	0.000672	0.0267	CcSEcCtD
Epinastine—Infection—Imiquimod—skin cancer	0.000665	0.0264	CcSEcCtD
Epinastine—Upper respiratory tract infection—Temozolomide—skin cancer	0.000655	0.026	CcSEcCtD
Epinastine—HRH1—lymph node—skin cancer	0.000621	0.00626	CbGeAlD
Epinastine—Pharyngitis—Dactinomycin—skin cancer	0.000619	0.0246	CcSEcCtD
Epinastine—ADRA2A—lymph node—skin cancer	0.00061	0.00615	CbGeAlD
Epinastine—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000604	0.0239	CcSEcCtD
Epinastine—ABCB1—lymphoid tissue—skin cancer	0.000602	0.00607	CbGeAlD
Epinastine—Sinusitis—Temozolomide—skin cancer	0.00059	0.0234	CcSEcCtD
Epinastine—ABCB1—female reproductive system—skin cancer	0.000581	0.00586	CbGeAlD
Epinastine—Pharyngitis—Temozolomide—skin cancer	0.00056	0.0222	CcSEcCtD
Epinastine—Pruritus—Vemurafenib—skin cancer	0.000555	0.022	CcSEcCtD
Epinastine—Sinusitis—Fluorouracil—skin cancer	0.000543	0.0216	CcSEcCtD
Epinastine—Rhinitis—Fluorouracil—skin cancer	0.000521	0.0207	CcSEcCtD
Epinastine—Pharyngitis—Fluorouracil—skin cancer	0.000516	0.0205	CcSEcCtD
Epinastine—Cough—Bleomycin—skin cancer	0.000508	0.0202	CcSEcCtD
Epinastine—Headache—Vemurafenib—skin cancer	0.000491	0.0195	CcSEcCtD
Epinastine—ABCB1—head—skin cancer	0.000485	0.00489	CbGeAlD
Epinastine—Nasopharyngitis—Docetaxel—skin cancer	0.000485	0.0192	CcSEcCtD
Epinastine—Pruritus—Imiquimod—skin cancer	0.000473	0.0188	CcSEcCtD
Epinastine—Infection—Bleomycin—skin cancer	0.000472	0.0187	CcSEcCtD
Epinastine—Infection—Dactinomycin—skin cancer	0.00044	0.0175	CcSEcCtD
Epinastine—Cough—Temozolomide—skin cancer	0.000429	0.017	CcSEcCtD
Epinastine—Headache—Imiquimod—skin cancer	0.000419	0.0166	CcSEcCtD
Epinastine—Infection—Temozolomide—skin cancer	0.000398	0.0158	CcSEcCtD
Epinastine—Rhinitis—Docetaxel—skin cancer	0.000376	0.0149	CcSEcCtD
Epinastine—Pharyngitis—Docetaxel—skin cancer	0.000372	0.0148	CcSEcCtD
Epinastine—Infection—Fluorouracil—skin cancer	0.000367	0.0146	CcSEcCtD
Epinastine—ABCB1—lymph node—skin cancer	0.00034	0.00343	CbGeAlD
Epinastine—Pruritus—Bleomycin—skin cancer	0.000336	0.0133	CcSEcCtD
Epinastine—Cough—Docetaxel—skin cancer	0.000285	0.0113	CcSEcCtD
Epinastine—Pruritus—Temozolomide—skin cancer	0.000284	0.0113	CcSEcCtD
Epinastine—Infection—Docetaxel—skin cancer	0.000265	0.0105	CcSEcCtD
Epinastine—Pruritus—Fluorouracil—skin cancer	0.000261	0.0104	CcSEcCtD
Epinastine—Headache—Temozolomide—skin cancer	0.000251	0.00996	CcSEcCtD
Epinastine—Headache—Fluorouracil—skin cancer	0.000231	0.00918	CcSEcCtD
Epinastine—Pruritus—Docetaxel—skin cancer	0.000189	0.00748	CcSEcCtD
Epinastine—Headache—Docetaxel—skin cancer	0.000167	0.00662	CcSEcCtD
